DHR vs SBUX: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Starbucks Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Starbucks Corporation · Consumer Cyclical
$100.65
-6.1% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
SBUX |
| Current Price |
$177.17 |
$100.65 |
| Fair Value Estimate |
$192.90 |
$94.50 |
| Upside to Fair Value |
+8.9%
|
-6.1%
|
| Market Cap |
$125.4B |
$114.7B |
| Forward P/E |
34.1x
|
76.7x
|
| EV / EBITDA |
20.8x
|
25.6x
|
| Price / Sales |
5.1x
|
3.0x
|
| Price / FCF |
23.7x
|
42.1x
|
| Revenue Growth YoY |
+3.7%
|
+8.8%
|
| Gross Margin |
60.7%
|
20.4%
|
| Operating Margin |
21.0%
|
9.3%
|
| Return on Equity |
7.1%
|
-18.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
2.38%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Starbucks Corporation operates a global coffeehouse chain with a strong brand and a leading digital/mobile platform, serving approximately 90 million customers weekly through over 28,000 stores in 77 countries. The company benefits from a durable competitive moat based on its extensive store footprint, brand recognition, and digital engagement rather than proprietary products. Despite solid reven…
Accumulation Zones
| Metric |
DHR |
SBUX |
| Zone Low |
$144.68 |
$70.88 |
| Zone High |
$163.97 |
$80.33 |
| In Buy Zone? |
No
|
No
|